In people with MS with comorbid fatigue and/or depression, there are reported increased serum and CSF concentrations of the pro-inflammatory cytokines, such as interleukins (IL-1a, IL-1b, IL-2, IL-6), TNF-α and IFN-γ. Here, IL2 is linked to myeloid sarcoma.